Therapeutic Areas

Viatris offers quality treatment options across major therapeutic areas covering a wide variety of noncommunicable and infectious diseases. We also offer support services such as diagnostic clinics, educational seminars and digital tools to help patients better manage their health.

We offer a broad and diverse range of treatment options across all our therapeutic areas, with many categories containing several products in a range of dosage forms, formulations and delivery systems that allow physicians to tailor care for optimal treatment.

Anti-Tubercular Therapy

Antiretroviral Therapy for HIV

CNS

COVID Therapy

Critical Care

Dermatology

Dermocosmetic

Gastroenterology

Infectious disease

Men’s Healthcare

Oncology

Ophthalmology

Pain Management

Transplant Care

We are committed to meaningfully reducing the burden of both noncommunicable and infectious diseases by leveraging our scientific, medical, manufacturing and commercial expertise to develop holistic, integrated solutions for diagnosis, prevention and treatment of these conditions.

Easing the burden of noncommunicable diseases

According to the World Health Organization (WHO), noncommunicable diseases (NCDs), such as ischemic heart disease, stroke, diabetes, certain cancers and chronic obstructive pulmonary disease, were among the leading causes of death globally as of 2019.1 NCDs affect people of every age, gender and socioeconomic status in every corner of the world, and pose a heavy burden on individuals, families and communities. To overcome this global public health threat, patients worldwide need a partner they can trust – one that not only believes everyone deserves good health, but also has the portfolio, experience and expertise to make this belief a reality.

To learn more about Viatris in NCDs, read our report “Creating an Integrated Approach to Noncommunicable Diseases”.

1https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.

Fighting infectious disease

We are also a global leader in treating infectious diseases such as HIV/AIDS, hepatitis and tuberculosis, and offer an extensive portfolio across these disease states. While many important strides have been made to treat these illnesses, there is still more to be done, especially in low- and lower-middle-income countries, where lack of access to therapeutics, preventative treatment and diagnostics often result in patients not receiving proper care. High-income countries face infectious disease challenges as well, where HIV transmission continues thirty years into the epidemic. From manufacturing a pediatric-friendly antiretroviral(ARV) used to treat HIV-positive infants to providing HIV self-tests in some low- and middle-income countries, we are innovating to help patients.